Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Nov 25, 2025 | PTC Therapeutics Inc. | Option exercise | +6,299 | $11.23 | $70,738 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −2,264 | $82.63 | $187,074 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −2,510 | $83.93 | $210,664 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −1,125 | $84.45 | $95,006 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −400 | $85.24 | $34,096 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Option exercise | +7,900 | $18.01 | $142,279 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −2,460 | $82.58 | $203,147 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −3,502 | $83.38 | $291,997 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −1,238 | $84.47 | $104,574 |
| Nov 25, 2025 | PTC Therapeutics Inc. | Open-market sale | −700 | $85.32 | $59,724 |
| Nov 24, 2025 | PTC Therapeutics Inc. | Option exercise | +5,701 | $11.23 | $64,022 |
| Nov 24, 2025 | PTC Therapeutics Inc. | Open-market sale | −5,701 | $80.13 | $456,821 |
| Nov 24, 2025 | PTC Therapeutics Inc. | Option exercise | +6,100 | $18.01 | $109,861 |
| Nov 24, 2025 | PTC Therapeutics Inc. | Open-market sale | −6,100 | $80.15 | $488,915 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.